An approach to immunologic reactions associated with plasma exchange
1Department of Medicine, University of Connecticut Health Center, Farmington 06030.
The Journal of Allergy and Clinical Immunology
|July 1, 1992
Summary
Anaphylactic-type reactions during pulmonary embolism (PE) treatment require further study. Strategies include addressing equipment issues, testing for immunogens, and considering premedication to manage risks.
Area of Science:
- Immunology
- Medical Devices
Background:
- Anaphylactic-type events are frequently observed during pulmonary embolism (PE) treatment.
- The underlying mechanisms of these immunologically mediated reactions remain poorly understood.
Observation:
- Potential causes include technique or equipment-related factors, such as biocompatibility of membranes and residual ethylene oxide.
- Reactions may also be linked to specific immunogens or the infusion of essential blood products.
Findings:
- Addressing equipment issues, like using biocompatible membranes and improved rinsing, can mitigate reactions.
- Investigating specific immunogens through in vivo or in vitro testing is recommended.
- Premedication regimens may be effective when blood product infusion is the suspected cause.
Implications:
- Management should prioritize preventing compromised oxygenation and perfusion in mother and fetus.
- Balancing treatment risks and benefits is crucial, focusing on symptom management and avoiding adverse drug effects.
- Further research into the pathogenesis of anaphylaxis in PE is warranted.
Related Concept Videos
Cross-reactivity
28.7K
Overview
28.7K
Blood Transfusion and Agglutination
13.0K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
13.0K
Immunoprecipitation
5.6K
Immunoprecipitation, or IP, is a widely used technique that employs protein-antibody interactions to isolate proteins or protein complexes in their native state for studying protein-protein interactions, quaternary structures, or supramolecular complexes. Various modifications of the technique, including chromatin IP, cross-linking IP, and fluorescence IP, are commonly used.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
5.6K
Allergic Drug Reactions
1.6K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.6K
Drug Toxicity: Allergic Reactions
209
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
209
Hypersensitivity Reactions: Immune-Complex Reactions
269
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum...
269


